本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kiniksa Pharmaceuticals Ltd.

20.05
-0.1600-0.79%
盤後19.05-1.0000-4.99%18:54 EDT
成交量:65.90萬
成交額:1,326.73萬
市值:14.57億
市盈率:-33.15
高:20.89
開:20.10
低:19.90
收:20.21
資料載入中...
2025/04/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

重要事件披露

Form 8-K - Current report
2025/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities